期刊
JOURNAL OF THE NEUROLOGICAL SCIENCES
卷 399, 期 -, 页码 97-100出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jns.2019.02.023
关键词
Myasthenia gravis; Nivolumab; Myocarditis; Myopathy; Programmed cell death protein 1 inhibitor; Thymoma